Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting Genetics Investing
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million Medical Device Investing
Elutia Announces Sale of BioEnvelope Business to Boston Scientific Corporation for $88 Million Medical Device Investing
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program Biotech Investing
BOTOX® Cosmetic Unveils "The One & Only" Campaign Featuring Real People and Their Distinctive Stories Pharmaceutical Investing
Cizzle Brands Launches HappiEats Sport Pasta, a Premium High Protein, Lower Glycemic Index Pasta Designed for Athletes of All Ages Biotech Investing
Cizzle Brands Launches HappiEats Sport Pasta, a Premium High Protein, Lower Glycemic Index Pasta Designed for Athletes of All Ages Biotech Investing
Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial Biotech Investing
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology Congress Biotech Investing
Nektar Announces REZOLVE-AD Phase 2b Results for Rezpegaldesleukin Selected for Late-Breaker Oral Presentation at EADV 2025 Pharmaceutical Investing
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis Biotech Investing
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS Biotech Investing
